```html

Unipolar Depression – Comprehensive Medical Guide

Overview

Unipolar depression, often simply called major depressive disorder (MDD), is a mood disorder characterized by a persistent feeling of sadness or a loss of interest in activities that were once enjoyable. Unlike bipolar disorder, which includes periods of elevated mood (mania or hypomania), unipolar depression involves only depressive episodes.

Who it affects: It can occur in people of any age, gender, race, or socioeconomic status, though prevalence varies by demographic factors. Women are diagnosed roughly 1.5–2 times more often than men, possibly due to hormonal, social, and reporting differences.

Prevalence: According to the World Health Organization (WHO), over 264 million people worldwide live with depression, making it the leading cause of disability globally. In the United States, the National Institute of Mental Health (NIMH) reports a 12‑month prevalence of 7.1 % (≈ 17 million adults) and a lifetime prevalence of 20.6 % among adults <sup>[1][2]</sup>.

Symptoms

Symptoms must be present for at least two weeks and represent a change from previous functioning. They are divided into emotional, cognitive, and physical domains.

Emotional / Mood Symptoms

• Persistent sadness or “empty” mood – feeling down most of the day, nearly every day.
• Loss of interest or pleasure (anhedonia) – no longer enjoying hobbies, work, or social activities.
• Feelings of hopelessness or helplessness – belief that nothing will improve.
• Excessive guilt or self‑criticism – disproportionate blame for real or imagined failures.

Cognitive Symptoms

• Difficulty concentrating – trouble focusing, making decisions, or remembering details.
• Indecisiveness – feeling “stuck” when trying to choose even simple options.
• Negative thought patterns – pervasive pessimism, rumination, or catastrophic thinking.

Physical / Somatic Symptoms

• Changes in appetite or weight – significant increase or decrease without trying.
• Sleep disturbances – insomnia, early‑morning awakening, or hypersomnia (excessive sleeping).
• Fatigue or loss of energy – feeling physically drained even after rest.
• Psychomotor agitation or retardation – restlessness or slowed movements and speech.
• Physical aches – headaches, back pain, or gastrointestinal issues without clear medical cause.

Severe / High‑Risk Symptoms

• Recurrent thoughts of death.
• Suicidal ideation or a specific plan.
• Self‑harm behaviors.

Causes and Risk Factors

Depression is multifactorial. No single cause explains every case, but several domains interact.

Biological Factors

• Neurotransmitter imbalances – especially serotonin, norepinephrine, and dopamine.
• Genetics – first‑degree relatives have a 2–3‑fold increased risk; heritability estimates ~40 %<sup>[3]</sup>.
• Hormonal changes – postpartum period, thyroid disorders, menopause, or cortisol dysregulation.
• Inflammation & immune response – elevated cytokines have been linked to depressive symptoms.

Psychological Factors

• Personality traits – perfectionism, high neuroticism, and low self‑esteem.
• Early life stress – childhood abuse, neglect, or loss.
• Coping style – maladaptive coping (rumination, avoidance) increases vulnerability.

Environmental / Social Factors

• Chronic stressors – financial problems, unemployment, or ongoing relationship conflict.
• Traumatic events – accidents, natural disasters, or military combat.
• Social isolation – lack of supportive relationships.
• Substance use – alcohol, nicotine, or illicit drugs can precipitate or worsen depression.

Who Is at Higher Risk?

• Women, especially during reproductive hormonal transitions.
• Individuals with a family history of mood disorders.
• People with chronic medical illnesses (e.g., diabetes, cardiovascular disease, chronic pain).
• Those who have experienced recent major life changes or trauma.
• Persons with a history of other mental health conditions (anxiety disorders, PTSD).

Diagnosis

Diagnosis is clinical—it relies on a thorough interview and standardized criteria.

Diagnostic Criteria

The DSM‑5 (American Psychiatric Association) defines major depressive episode as ≥5 of the 9 symptoms listed above, present during the same 2‑week period, representing a change from prior functioning, and causing distress or impairment. At least one symptom must be either depressed mood or anhedonia.

Assessment Tools

• Patient Health Questionnaire‑9 (PHQ‑9) – a 9‑item self‑report used in primary care.
• Beck Depression Inventory (BDI‑II) – widely used in research and clinical settings.
• Hamilton Rating Scale for Depression (HAM‑D) – clinician‑rated, useful for tracking treatment response.

Laboratory & Imaging Tests

These are not diagnostic for depression but help rule out medical mimics:

• Complete blood count (CBC) and metabolic panel – detect anemia, thyroid disease, electrolyte imbalances.
• Thyroid‑stimulating hormone (TSH) – hypothyroidism can present with depressive symptoms.
• Vitamin B12, folate, and vitamin D levels.
• In select cases, brain MRI or CT if neurological signs are present.

Differential Diagnosis

Conditions that can mimic depression include hypothyroidism, anemia, chronic fatigue syndrome, bipolar disorder (depressive phase), substance‑induced mood disorders, and certain neurodegenerative diseases.

Treatment Options

Effective treatment typically combines pharmacotherapy, psychotherapy, and lifestyle modifications.

Medications

• Selective Serotonin Reuptake Inhibitors (SSRIs) – e.g., sertraline, fluoxetine, escitalopram. First‑line due to favorable side‑effect profile.<sup>[4]</sup>
• Serotonin‑Norepinephrine Reuptake Inhibitors (SNRIs) – venlafaxine, duloxetine; useful when pain co‑exists.
• Atypical antidepressants – bupropion (dopamine/norepinephrine), mirtazapine (sedating, helpful for insomnia/weight loss).
• Tricyclic antidepressants (TCAs) and Monoamine Oxidase Inhibitors (MAOIs) – effective but reserved for treatment‑resistant cases due to higher toxicity.
• Adjunctive agents – low‑dose atypical antipsychotics (e.g., aripiprazole), lithium, or thyroid hormone in refractory depression.

Medication response usually begins within 2–4 weeks; full effect may take 6–8 weeks. Regular follow‑up is essential to monitor efficacy and side effects.

Psychotherapy

• Cognitive‑Behavioral Therapy (CBT) – targets negative thought patterns; strong evidence for moderate‑severity depression.
<
• Interpersonal Therapy (IPT) – focuses on relationship issues and role transitions.
• Behavioral Activation – encourages engagement in rewarding activities, counteracting avoidance.
• Mindfulness‑Based Cognitive Therapy (MBCT) – reduces relapse risk, especially in recurrent depression.

Procedural & Biological Treatments

• Electroconvulsive Therapy (ECT) – highly effective for severe, treatment‑resistant, or psychotic depression; administered under anesthesia.
• Repetitive Transcranial Magnetic Stimulation (rTMS) – non‑invasive, FDA‑approved for adults with MDD who have not responded to at least one antidepressant.
• Vagus Nerve Stimulation (VNS) and Ketamine/ESK‑line (intravenous or nasal) – emerging options for rapid symptom relief in resistant cases.

Lifestyle & Self‑Management

• Physical activity – 150 minutes of moderate aerobic exercise per week improves mood (comparable effect size to antidepressants).<sup>[5]</sup>
• Sleep hygiene – consistent bedtime, limiting screens, and creating a dark, quiet environment.
• Nutrition – Mediterranean‑style diet rich in omega‑3 fatty acids, fruits, vegetables, and whole grains may lower depressive symptoms.
• Limit alcohol & caffeine – both can exacerbate anxiety and disrupt sleep.
• Social connection – regular contact with friends/family or support groups reduces isolation.

Living with Unipolar Depression

Managing depression is an ongoing process. Here are practical strategies for daily life:

Routine & Structure

• Set a consistent wake‑up and sleep schedule.
• Break tasks into small, achievable steps; use checklists or reminder apps.

Activity Scheduling

• Plan at least one pleasurable activity each day, even if it feels “forced” at first.
• Incorporate brief movement breaks (e.g., 5‑minute walk) to combat fatigue.

Thought Management

• Use CBT worksheets to identify cognitive distortions (all‑or‑nothing thinking, catastrophizing).
• Practice mindfulness meditation for 10‑15 minutes daily to increase present‑moment awareness.

Medication Adherence

• Take medication at the same time each day; use pillboxes or phone alarms.
• Report side‑effects promptly; never stop a drug abruptly without consulting a provider.

Build a Support Network

• Share your diagnosis with trusted friends or family.
• Join a depression support group (in‑person or online) to reduce stigma and learn coping tips.

Professional Follow‑up

• Schedule regular appointments (usually every 4–6 weeks initially) to assess response.
• Consider tele‑health options if transportation or anxiety is a barrier.

Prevention

While not all cases can be prevented, risk can be lowered through proactive measures:

• Stress‑management training – progressive muscle relaxation, yoga, or biofeedback.
• Early treatment of sub‑threshold depressive symptoms – brief CBT or counseling can halt progression.
• Routine screening for depression in primary care, especially for high‑risk groups (e.g., postpartum women).
• Maintain physical health – regular exercise, a balanced diet, and adequate sleep.
• Avoid excessive alcohol or recreational drug use.

Complications

If left untreated, unipolar depression can lead to serious physical, emotional, and social consequences:

• Suicide – the 10th leading cause of death in the U.S.; risk escalates with prior attempts, mixed‑type features, or severe hopelessness.<sup>[6]</sup>
• Chronic medical illnesses – depression worsens outcomes in heart disease, diabetes, and chronic pain.
• Reduced functional capacity – impairments in work performance, school achievement, and household responsibilities.
• Relationship strain – family and social networks often experience conflict or isolation.
• Substance use disorders – self‑medication with alcohol or drugs can develop.

When to Seek Emergency Care

---

References

1. World Health Organization. Depression and Other Common Mental Disorders: Global Health Estimates. 2022.
2. National Institute of Mental Health. Major Depression. 2023. https://www.nimh.nih.gov/health/statistics/major-depression
3. Levinson DF. Genetics of Mood Disorders: Current Findings and Implications for Clinical Practice. J Clin Psychiatry. 2021.
4. American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 2021.
5. Cooney GM, et al. Exercise for depression. Cochrane Database Syst Rev. 2022; (9):CD004366.
6. Centers for Disease Control and Prevention. Suicide Mortality Among Adults — United States, 2019–2022. 2023.

```